Document Actions
Integrated Platforms for Unknown or Attenuated Disease Agent Characterization
Pathogens encountered in the future may differ substantially and in unknown ways from those identified and characterized today, either by natural or intentional attenuation. To address this gap, the FAZD Center is developing with its partners a suite of universal, unbiased, and massively parallel micro- and nano-analytical devices that can collect, compare, and archive genetic biosignature information to effectively categorize and contribute to the development of strategies for outbreaks of unknown etiology. This suite of technologies includes the Integrated Biomarker Specific Biosignature (IBSB), Multiple Select Agent Specific (MSAS), and Universal Biosignature Detection Array (UBDA) platform technologies.
Principal Investigator: Garry Adams,
FAZD Center Theme Leader: Biological Systems, Texas A&M
University. Professor of Veterinary Pathology and Associate Dean for
Homeland Security for the College of Veterinary Medicine. Research
areas include studies of the genetic basis of natural disease
resistance, molecular pathogenesis of intracellular bacterial
pathogens, and the development of vaccines and diagnostic tests against
zoonotic diseases. Published research.